Nutex Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Revenue	292	247.65	219.29	331.53	274.03	97.06
Revenue Growth (YoY)	26.02%	12.93%	-33.85%	20.98%	182.34%	-
Cost of Revenue	205.78	195.28	190.74	144.59	104.56	40.17
Gross Profit	86.22	52.37	28.55	186.94	169.47	56.89
Selling, General & Admin	37.43	33.23	19.81	5.46	10.4	19.7
Operating Expenses	58.64	53.66	33.13	13.12	16.29	22.18
Operating Income	27.58	-1.29	-4.58	173.82	153.17	34.71
Interest Expense	-19.12	-16.32	-12.49	-6.2	-6.43	-3.53
Other Non Operating Income (Expenses)	-0.69	-0.4	-0.56	-0.12	-1	0.91
EBT Excluding Unusual Items	7.78	-18.01	-17.63	167.5	145.74	32.09
Merger & Restructuring Charges	-29.08	-29.34	-3.89	-3.55	-	-
Impairment of Goodwill	-4.34	-1.14	-398.14	-	-	-
Other Unusual Items	-	-	-	5.55	-	-
Pretax Income	-29.54	-48.49	-419.65	169.49	145.74	32.09
Income Tax Expense	2.87	-5.07	13.09	0.97	0.18	-
Earnings From Continuing Operations	-32.41	-43.42	-432.74	168.53	145.56	32.09
Minority Interest in Earnings	-8.73	-2.36	7.96	-35.93	-39.59	-11.17
Net Income	-41.13	-45.79	-424.78	132.59	105.97	20.92
Net Income to Common	-41.13	-45.79	-424.78	132.59	105.97	20.92
Net Income Growth	-	-	-	25.12%	406.47%	-
Shares Outstanding (Basic)	5	4	4	4	4	-
Shares Outstanding (Diluted)	5	4	4	4	4	-
Shares Change (YoY)	10.96%	4.15%	7.10%	-	-	-
EPS (Basic)	-8.48	-10.39	-100.36	33.55	26.81	-
EPS (Diluted)	-8.58	-10.50	-100.50	33.00	26.81	-
EPS Growth	-	-	-	23.07%	-	-
Free Cash Flow	20.24	-8.24	35.97	136.51	25.48	-20.15
Free Cash Flow Per Share	4.17	-1.87	8.50	34.54	6.45	-
Gross Margin	29.53%	21.14%	13.02%	56.39%	61.84%	58.61%
Operating Margin	9.45%	-0.52%	-2.09%	52.43%	55.90%	35.76%
Profit Margin	-14.09%	-18.49%	-193.70%	39.99%	38.67%	21.56%
Free Cash Flow Margin	6.93%	-3.33%	16.41%	41.17%	9.30%	-20.76%
EBITDA	36.2	6.25	1.43	179.09	156.66	37.19
EBITDA Margin	12.40%	2.52%	0.65%	54.02%	57.17%	38.32%
D&A For EBITDA	8.62	7.54	6.01	5.27	3.48	2.48
EBIT	27.58	-1.29	-4.58	173.82	153.17	34.71
EBIT Margin	9.45%	-0.52%	-2.09%	52.43%	55.90%	35.76%
Effective Tax Rate	-	-	-	0.57%	0.12%	-
Revenue as Reported	292	247.65	219.29	331.53	274.03	-

Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q